Report Detail
Global (United States, European Union and China) Human Rabies Vaccines Market Research Report 2019-2025
- RnM3674851 |
- 16 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.
Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.
In 2019, the market size of Human Rabies Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Rabies Vaccines.
This report studies the global market size of Human Rabies Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Rabies Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi Pasteur，Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck＆Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
Market Segment by Product Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Market Segment by Application
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Rabies Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Rabies Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Rabies Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Human Rabies Vaccines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Vero Cell Rabies Vaccine
- 1.3.3 BHK
- 1.3.4 Chick Embryo Cell Rabies Vaccine
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Human Rabies Vaccines Market Share by Application (2019-2025)
- 1.4.2 Pre-Exposure Prophylaxis
- 1.4.3 Post-Exposure Prophylaxis
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Human Rabies Vaccines Market Size
- 2.1.1 Global Human Rabies Vaccines Revenue 2014-2025
- 2.1.2 Global Human Rabies Vaccines Sales 2014-2025
- 2.2 Human Rabies Vaccines Growth Rate by Regions
- 2.2.1 Global Human Rabies Vaccines Sales by Regions 2014-2019
- 2.2.2 Global Human Rabies Vaccines Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Human Rabies Vaccines Sales by Manufacturers
- 3.1.1 Human Rabies Vaccines Sales by Manufacturers 2014-2019
- 3.1.2 Human Rabies Vaccines Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Human Rabies Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Rabies Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Human Rabies Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.3 Human Rabies Vaccines Price by Manufacturers
- 3.4 Key Manufacturers Human Rabies Vaccines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Human Rabies Vaccines Market
- 3.6 Key Manufacturers Human Rabies Vaccines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Vero Cell Rabies Vaccine Sales and Revenue (2014-2019)
- 4.1.2 BHK Sales and Revenue (2014-2019)
- 4.1.3 Chick Embryo Cell Rabies Vaccine Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Human Rabies Vaccines Sales Market Share by Type
- 4.3 Global Human Rabies Vaccines Revenue Market Share by Type
- 4.4 Human Rabies Vaccines Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Human Rabies Vaccines Sales by Application
6 United States
- 6.1 United States Human Rabies Vaccines Breakdown Data by Company
- 6.2 United States Human Rabies Vaccines Breakdown Data by Type
- 6.3 United States Human Rabies Vaccines Breakdown Data by Application
7 European Union
- 7.1 European Union Human Rabies Vaccines Breakdown Data by Company
- 7.2 European Union Human Rabies Vaccines Breakdown Data by Type
- 7.3 European Union Human Rabies Vaccines Breakdown Data by Application
8 China
- 8.1 China Human Rabies Vaccines Breakdown Data by Company
- 8.2 China Human Rabies Vaccines Breakdown Data by Type
- 8.3 China Human Rabies Vaccines Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Human Rabies Vaccines Breakdown Data by Company
- 9.2 Rest of World Human Rabies Vaccines Breakdown Data by Type
- 9.3 Rest of World Human Rabies Vaccines Breakdown Data by Application
- 9.4 Rest of World Human Rabies Vaccines Breakdown Data by Countries
- 9.4.1 Rest of World Human Rabies Vaccines Sales by Countries
- 9.4.2 Rest of World Human Rabies Vaccines Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi Pasteur，Inc.
- 10.1.1 Sanofi Pasteur，Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.1.4 Human Rabies Vaccines Product Introduction
- 10.1.5 Sanofi Pasteur，Inc. Recent Development
- 10.2 Novartis Vaccines and Diagnostics Ltd.
- 10.2.1 Novartis Vaccines and Diagnostics Ltd. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.2.4 Human Rabies Vaccines Product Introduction
- 10.2.5 Novartis Vaccines and Diagnostics Ltd. Recent Development
- 10.3 Cadila Pharmaceuticals Ltd.
- 10.3.1 Cadila Pharmaceuticals Ltd. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.3.4 Human Rabies Vaccines Product Introduction
- 10.3.5 Cadila Pharmaceuticals Ltd. Recent Development
- 10.4 GlaxoSmithKline Biologicals
- 10.4.1 GlaxoSmithKline Biologicals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.4.4 Human Rabies Vaccines Product Introduction
- 10.4.5 GlaxoSmithKline Biologicals Recent Development
- 10.5 Merck＆Co Inc.
- 10.5.1 Merck＆Co Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.5.4 Human Rabies Vaccines Product Introduction
- 10.5.5 Merck＆Co Inc. Recent Development
- 10.6 Wyeth pharmaceuticals
- 10.6.1 Wyeth pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.6.4 Human Rabies Vaccines Product Introduction
- 10.6.5 Wyeth pharmaceuticals Recent Development
- 10.7 Berna Biotech Ltd.
- 10.7.1 Berna Biotech Ltd. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.7.4 Human Rabies Vaccines Product Introduction
- 10.7.5 Berna Biotech Ltd. Recent Development
- 10.8 Medimmune LLC
- 10.8.1 Medimmune LLC Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Human Rabies Vaccines
- 10.8.4 Human Rabies Vaccines Product Introduction
- 10.8.5 Medimmune LLC Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Human Rabies Vaccines Sales Channels
- 11.2.2 Human Rabies Vaccines Distributors
- 11.3 Human Rabies Vaccines Customers
12 Market Forecast
- 12.1 Global Human Rabies Vaccines Sales and Revenue Forecast 2019-2025
- 12.2 Global Human Rabies Vaccines Sales Forecast by Type
- 12.3 Global Human Rabies Vaccines Sales Forecast by Application
- 12.4 Human Rabies Vaccines Forecast by Regions
- 12.4.1 Global Human Rabies Vaccines Sales Forecast by Regions 2019-2025
- 12.4.2 Global Human Rabies Vaccines Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Human Rabies Vaccines. Industry analysis & Market Report on Human Rabies Vaccines is a syndicated market report, published as Global (United States, European Union and China) Human Rabies Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Rabies Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
